Ipratropiumbromide/Salbutamol Sandoz

Ipratropium bromide and Salbutamol, the active ingredients in Ipratropiumbromide/Salbutamol Sandoz, are an anticholinergic bronchodilator and a β2‑adrenergic agonist presented as a combination inhalation solution for inhalation use. It provides bronchodilation for patients with chronic obstructive pulmonary disease, asthma and acute bronchospasm.

GNH USA supplies Ipratropiumbromide/Salbutamol Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ipratropiumbromide/Salbutamol Sandoz is a combination bronchodilator used in respiratory disorders that cause airway narrowing. - Chronic obstructive pulmonary disease (COPD): improves airflow and reduces bronchospasm. - Asthma: provides rapid bronchodilation to relieve symptoms. - Acute bronchospasm: quickly alleviates sudden airway constriction.

The following adverse reactions have been reported with the inhaled combination of ipratropium bromide and salbutamol.

Common Side Effects: - Dry mouth: mild to moderate dryness of the oral cavity. - Cough: transient irritation leading to coughing. - Throat irritation: discomfort or soreness in the throat. - Tremor: fine shaking, often of the hands. - Headache: mild to moderate headache. - Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects: - Paradoxical bronchospasm: worsening of airway constriction after inhalation. - Angioedema: swelling of the face, lips, tongue or throat. - Tachyarrhythmia: rapid or irregular heart rhythm. - Severe allergic reaction: anaphylaxis with rash, itching, swelling. - Chest pain: unexplained discomfort in the chest area.

Before prescribing Ipratropiumbromide/Salbutamol Sandoz, consider the following safety measures. - Assess respiratory status: evaluate baseline lung function and severity of disease. - Monitor for paradoxical bronchospasm: watch for worsening breathing after use. - Use with caution in cardiovascular disease: beta‑agonists may affect heart rate and blood pressure. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Adjust in renal impairment: consider reduced clearance of ipratropium. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Ipratropiumbromide/Salbutamol Sandoz may interact with other medicines; review patient medication lists.

Major Interactions (Avoid): - Beta‑blockers: may diminish bronchodilator effect and precipitate bronchospasm. - MAO inhibitors: can increase risk of cardiovascular side effects. - Tricyclic antidepressants: may enhance tachycardia and arrhythmias.

Moderate Interactions (Monitor Closely):\n- Theophylline: additive stimulant effect on the heart and CNS. - Antihistamines: may increase anticholinergic burden leading to dry mouth or urinary retention.